274 related articles for article (PubMed ID: 22082548)
1. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
[TBL] [Abstract][Full Text] [Related]
2. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
3. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
[TBL] [Abstract][Full Text] [Related]
4. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
[TBL] [Abstract][Full Text] [Related]
5. [MR subtraction in the differentiation of benign and malignant tumors].
Sun J; Bian D; Xiao E; Situ W; He Z; Li H; Yuan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 38(10):997-1002. PubMed ID: 24164890
[TBL] [Abstract][Full Text] [Related]
6. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
[TBL] [Abstract][Full Text] [Related]
7. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
8. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
9. Computerized breast lesions detection using kinetic and morphologic analysis for dynamic contrast-enhanced MRI.
Chang YC; Huang YH; Huang CS; Chen JH; Chang RF
Magn Reson Imaging; 2014 Jun; 32(5):514-22. PubMed ID: 24582545
[TBL] [Abstract][Full Text] [Related]
10. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced subtraction MRI for characterizing intratesticular mass lesions.
Tsili AC; Argyropoulou MI; Astrakas LG; Ntoulia EA; Giannakis D; Sofikitis N; Tsampoulas K
AJR Am J Roentgenol; 2013 Mar; 200(3):578-85. PubMed ID: 23436847
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
[TBL] [Abstract][Full Text] [Related]
14. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
16. Chemical shift MRI: is there any contribution to morphologic evaluation of solid breast masses?
Gokalp G; Topal U; Bolca N; Ercan I
Acad Radiol; 2009 Oct; 16(10):1263-71. PubMed ID: 19608436
[TBL] [Abstract][Full Text] [Related]
17. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
Cheung HS; Tse GM; Lai SY; Yeung DK
Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of probably benign breast MRI lesions.
Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
20. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
